Penumbra (PEN) Interest & Investment Income (2014 - 2026)
Penumbra (PEN) reported Interest & Investment Income of $3.5 million for Q1 2026, down 1.54% year-over-year from $3.5 million in Q1 2025, and down 0.95% on a QoQ basis from $3.5 million in Q3 2025.
Penumbra (PEN) has 13 years of Interest & Investment Income data on file, last reported at $3.5 million in Q1 2026.
- Quarterly Interest & Investment Income fell 1.54% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.9 million (up 10.32% YoY) and the FY2022 annual result came in at $137000.0, down 85.39% from the prior year.
- Interest & Investment Income fell to $3.5 million in Q1 2026 per PEN's latest filing, from $3.5 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $4.5 million in Q2 2025 and bottomed at -$72000.0 in Q2 2022.
- The 5-year median for Interest & Investment Income is $2.1 million (2023), against an average of $2.0 million.
- The widest annual swing landed in 2022, when Interest & Investment Income sank 131.16%; it then jumped 2387.5% in 2023.
- Tracing PEN's Interest & Investment Income over 5 years: stood at $299000.0 in 2022, then surged by 127.09% to $679000.0 in 2023, then surged by 550.07% to $4.4 million in 2024, then decreased by 21.0% to $3.5 million in 2025, then declined by 0.95% to $3.5 million in 2026.
- Per Business Quant, the three latest PEN Interest & Investment Income figures stand at $3.5 million (Q1 2026), $3.5 million (Q3 2025), and $4.5 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -25.76 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn | 3.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.45 Mn |
| Sep 30, 2025 | 3.49 Mn |
| Jun 30, 2025 | 4.48 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Sep 30, 2024 | 4.41 Mn |
| Jun 30, 2024 | 3.09 Mn |
| Mar 31, 2024 | 2.53 Mn |
| Sep 30, 2023 | 679,000.00 |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 644,000.00 |
| Dec 31, 2022 | 299,000.00 |
| Sep 30, 2022 | -43,000.00 |
| Jun 30, 2022 | -72,000.00 |
| Mar 31, 2022 | -47,000.00 |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 138,000.00 |
| Jun 30, 2021 | 299,000.00 |
| Mar 31, 2021 | 480,000.00 |
| Dec 31, 2020 | 447,000.00 |
| Sep 30, 2020 | 413,000.00 |
| Jun 30, 2020 | 108,000.00 |
| Mar 31, 2020 | 299,000.00 |
| Dec 31, 2019 | 578,000.00 |
| Sep 30, 2019 | 759,000.00 |
| Jun 30, 2019 | 784,000.00 |
| Mar 31, 2019 | 733,000.00 |
| Dec 31, 2018 | 724,000.00 |
| Sep 30, 2018 | 771,000.00 |
| Jun 30, 2018 | 720,000.00 |
| Mar 31, 2018 | 749,000.00 |
| Dec 31, 2017 | 727,000.00 |
| Sep 30, 2017 | 658,000.00 |
| Jun 30, 2017 | 624,000.00 |
| Mar 31, 2017 | 644,000.00 |
| Dec 31, 2016 | 623,000.00 |
| Sep 30, 2016 | 631,000.00 |
| Jun 30, 2016 | 559,000.00 |
| Mar 31, 2016 | 510,000.00 |
| Dec 31, 2015 | 139,000.00 |
| Sep 30, 2015 | 17,000.00 |
| Jun 30, 2015 | 177,000.00 |
| Mar 31, 2015 | 208,000.00 |
| Dec 31, 2014 | 256,000.00 |
| Sep 30, 2014 | 144,000.00 |